Bin He
Bin He has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Xihua Chen
14 shared publicationsXiangbo Xu
Graduate School of Peking Union Medical College, Beijing 100730, China; NHC Key Laboratory of Reproductive Health Engineering Technology Research, Department of Reproduction and Physiology, National Research Institute for Family Planning, Beijing 100081, China
11 shared publications- Yufeng Zheng
School of Materials Science and Engineering Peking University Beijing China
11 shared publications Jianbing Liu
School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, 030001, People’s Republic of China
8 shared publicationsShufang Wang
Reproductive Physiology Laboratory, National Research Institute for Family Planning, Beijing, 100081, People’s Republic of China
8 shared publicationsHaoqi Zhao
Reproductive Physiology Laboratory, National Research Institute for Family Planning, Beijing, 100081, People’s Republic of China
7 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 524-540
Bimetallic nanozymes with galvanic cell effects eradicate intratumoral bacteria and tumor cells to overcome drug resistance and potentiate antitumor immune responses for tumor therapy
Intratumoral bacteria have attracted considerable attention as critical components of the tumor microenvironment (TME) that influence tumor initiation, progression, therapeutic efficacy, and immune responses. Conventional antibiotic approaches for eradicating intratumoral bacteria are limited by severe side effects, disruption of microbial homeostasis, and the emergence of multidrug resistance, while offering no direct tumoricidal effects. Here, we developed bimetallic Copper-Tin nanozymes (CuSn nanozymes) with a galvanic cell effect to overcome bacteria-associated challenges, overcome drug resistance, and enhance cancer therapy. The nanozymes can generate highly active electrons and metal ions at tumor sites without external stimulation, achieving massive reactive oxygen species (ROS) production and effective tumor eradication. The released electrons disrupt bacterial electron transport chains (ETC), thereby inhibiting energy synthesis and achieving potent antibacterial effects. The release of copper ions further enhances ROS-mediated antibacterial activity. Moreover, bacterial eradication promotes antitumor immune activation, further enhancing therapeutic outcomes. Using breast, endometrial, and liver cancer models, we demonstrated the broad applicability of this approach. This work not only offers a new paradigm for designing innovative bimetallic nanozymes with enhanced catalytic activity but also provides a potential therapeutic approach for simultaneously eliminating bacteria and tumors, overcoming chemoresistance, and offering effective treatment without reliance on conventional antibiotics or chemotherapeutics for microbiota-enriched tumors.
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 524-540
Open AccessBimetallic nanozymes with galvanic cell effects eradicate intratumoral bacteria and tumor cells to overcome drug resistance and potentiate antitumor immune responses for tumor therapy
Intratumoral bacteria have attracted considerable attention as critical components of the tumor microenvironment (TME) that influence tumor initiation, progression, therapeutic efficacy, and immune responses. Conventional antibiotic approaches for eradicating intratumoral bacteria are limited by severe side effects, disruption of microbial homeostasis, and the emergence of multidrug resistance, while offering no direct tumoricidal effects. Here, we developed bimetallic Copper-Tin nanozymes (CuSn nanozymes) with a galvanic cell effect to overcome bacteria-associated challenges, overcome drug resistance, and enhance cancer therapy. The nanozymes can generate highly active electrons and metal ions at tumor sites without external stimulation, achieving massive reactive oxygen species (ROS) production and effective tumor eradication. The released electrons disrupt bacterial electron transport chains (ETC), thereby inhibiting energy synthesis and achieving potent antibacterial effects. The release of copper ions further enhances ROS-mediated antibacterial activity. Moreover, bacterial eradication promotes antitumor immune activation, further enhancing therapeutic outcomes. Using breast, endometrial, and liver cancer models, we demonstrated the broad applicability of this approach. This work not only offers a new paradigm for designing innovative bimetallic nanozymes with enhanced catalytic activity but also provides a potential therapeutic approach for simultaneously eliminating bacteria and tumors, overcoming chemoresistance, and offering effective treatment without reliance on conventional antibiotics or chemotherapeutics for microbiota-enriched tumors.
- 7 March 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 214, 210-225
Thermosensitive hydrogel delivers nanoparticles for the modulation of immune homeostasis for salpingitis therapy
- 7 March 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 214, 210-225
Thermosensitive hydrogel delivers nanoparticles for the modulation of immune homeostasis for salpingitis therapy
- 18 December 2025
- Published by Elsevier in Biomaterials
- Vol. 329, 123915
Stimuli-responsive nanomaterials for eradicating intratumoral bacteria and augmenting tumor therapy efficiency: progress and perspectives
- 18 December 2025
- Published by Elsevier in Biomaterials
- Vol. 329, 123915
Stimuli-responsive nanomaterials for eradicating intratumoral bacteria and augmenting tumor therapy efficiency: progress and perspectives
- Open Access
- 7 August 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 204, 624-642
Design of low-dose, non-hormonal female contraceptives targeting trophoblast cells using vitamin B13 copper metal-organic frameworks
- 7 August 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 204, 624-642
Open AccessDesign of low-dose, non-hormonal female contraceptives targeting trophoblast cells using vitamin B13 copper metal-organic frameworks
- Open Access
- 1 October 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 189, 651-667
Mitigating adverse effects of Cu-containing intrauterine devices using a highly biocompatible Cu 5Fe alloy
- 1 October 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 189, 651-667
Open AccessMitigating adverse effects of Cu-containing intrauterine devices using a highly biocompatible Cu 5Fe alloy
- Open Access
- 1 June 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 36, 96-111
Combination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
Endometrial cancer (EC) stands as one of the most prevalent gynecological malignancies affecting women, with its incidence and disease-related mortality steadily on the rise. Disulfiram (DSF), an FDA-approved medication primarily used for treating alcohol addiction, has exhibited promising anti-tumor properties. Studies have revealed DSF's capacity for enhanced anti-tumor activity, particularly when combined with copper. The novel Copper-Cysteamine (CuCy) compound, Cu3Cl(SR)2 (R Created by potrace 1.16, written by Peter Selinger 2001-2019 CH2CH2NH2), showcases photodynamic effects and demonstrates significant anti-tumor potential under various conditions, including exposure to ultraviolet light, X-ray, microwave, and ultrasound. This study delves into exploring the synergistic anti-tumor effects and underlying mechanisms by utilizing copper-cysteamine in conjunction with DSF against endometrial cancer. The investigation involved comprehensive analyses encompassing in vitro experiments utilizing Ishikawa cells, in vivo studies, and transcriptomic analyses. Remarkably, the combined administration of both compounds at a low dose of 0.5 μM exhibited pronounced efficacy in impeding tumor growth, inhibiting blood vessel formation, and stimulating cell apoptosis. Notably, experiments involving transplanted tumors in nude mice vividly demonstrated the significant in vivo anti-tumor effects of this combination treatment. Detailed examination through transmission electron microscopy unveiled compelling evidence of mitochondrial damage, cellular swelling, and rupture, indicative of apoptotic changes in morphology due to the combined treatment. Moreover, transcriptomic analysis unveiled substantial downregulation of mitochondrial-related genes at the molecular level, coupled with a significant hindrance in the DNA repair pathway. These findings strongly suggest that the combined application of CuCy and DSF induces mitochondrial impairment in Ishikawa cells, thereby fostering apoptosis and ultimately yielding potent anti-tumor effects.
- 1 June 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 36, 96-111
Open AccessCombination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
Endometrial cancer (EC) stands as one of the most prevalent gynecological malignancies affecting women, with its incidence and disease-related mortality steadily on the rise. Disulfiram (DSF), an FDA-approved medication primarily used for treating alcohol addiction, has exhibited promising anti-tumor properties. Studies have revealed DSF's capacity for enhanced anti-tumor activity, particularly when combined with copper. The novel Copper-Cysteamine (CuCy) compound, Cu3Cl(SR)2 (R Created by potrace 1.16, written by Peter Selinger 2001-2019 CH2CH2NH2), showcases photodynamic effects and demonstrates significant anti-tumor potential under various conditions, including exposure to ultraviolet light, X-ray, microwave, and ultrasound. This study delves into exploring the synergistic anti-tumor effects and underlying mechanisms by utilizing copper-cysteamine in conjunction with DSF against endometrial cancer. The investigation involved comprehensive analyses encompassing in vitro experiments utilizing Ishikawa cells, in vivo studies, and transcriptomic analyses. Remarkably, the combined administration of both compounds at a low dose of 0.5 μM exhibited pronounced efficacy in impeding tumor growth, inhibiting blood vessel formation, and stimulating cell apoptosis. Notably, experiments involving transplanted tumors in nude mice vividly demonstrated the significant in vivo anti-tumor effects of this combination treatment. Detailed examination through transmission electron microscopy unveiled compelling evidence of mitochondrial damage, cellular swelling, and rupture, indicative of apoptotic changes in morphology due to the combined treatment. Moreover, transcriptomic analysis unveiled substantial downregulation of mitochondrial-related genes at the molecular level, coupled with a significant hindrance in the DNA repair pathway. These findings strongly suggest that the combined application of CuCy and DSF induces mitochondrial impairment in Ishikawa cells, thereby fostering apoptosis and ultimately yielding potent anti-tumor effects.
- RetractionOpen Access
- 18 December 2023
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 27 (2) , 1
[Retracted] MicroRNA‑138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF‑1α
[This retracts the article DOI: 10.3892/etm.2016.3220.].
- 18 December 2023
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 27 (2) , 1
RetractionOpen Access[Retracted] MicroRNA‑138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF‑1α
[This retracts the article DOI: 10.3892/etm.2016.3220.].
- 18 January 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (6) , 1724-1736
Repairing and Regenerating Injured Endometrium Methods
Good endometrium is the prerequisite and guarantee for reproduction and maternal and child health. Endometrial injury caused by operation or non-operation can lead to menstrual irregularities, amenorrhea, abortion, infertility, and other gynecological diseases to bother women. Intrauterine adhesions (IUA) and thin endometrium are common diseases caused by abnormal repair after endometrium damage. The incidence of IUA is not low after uterine operative surgery, and the recurrence is pretty high after uterine adhesiolysis. At present, there were many methods for endometrial repair in clinic or in the laboratory, but the efficacy was different from methods to methods. They are mainly including estrogen therapy, stem cell therapy, complementary medicine therapy, and some physical barrier therapy. In order to guide the effective repair and regeneration of endometrium in clinic, this paper reviews the merit and demerit of these methods for endometrium regeneration and repair that have been proved to be effective in experiments and clinical in recent years.
- 18 January 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (6) , 1724-1736
Repairing and Regenerating Injured Endometrium Methods
Good endometrium is the prerequisite and guarantee for reproduction and maternal and child health. Endometrial injury caused by operation or non-operation can lead to menstrual irregularities, amenorrhea, abortion, infertility, and other gynecological diseases to bother women. Intrauterine adhesions (IUA) and thin endometrium are common diseases caused by abnormal repair after endometrium damage. The incidence of IUA is not low after uterine operative surgery, and the recurrence is pretty high after uterine adhesiolysis. At present, there were many methods for endometrial repair in clinic or in the laboratory, but the efficacy was different from methods to methods. They are mainly including estrogen therapy, stem cell therapy, complementary medicine therapy, and some physical barrier therapy. In order to guide the effective repair and regeneration of endometrium in clinic, this paper reviews the merit and demerit of these methods for endometrium regeneration and repair that have been proved to be effective in experiments and clinical in recent years.
- 30 January 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 142, 374-387
Feasibility evaluation of a Zn-Cu alloy for intrauterine devices: In vitro and in vivo studies
- 30 January 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 142, 374-387
Feasibility evaluation of a Zn-Cu alloy for intrauterine devices: In vitro and in vivo studies
- 1 January 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 138, 561-575
Feasibility evaluation of a Cu-38 Zn alloy for intrauterine devices: In vitro and in vivo studies
- 1 January 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 138, 561-575
Feasibility evaluation of a Cu-38 Zn alloy for intrauterine devices: In vitro and in vivo studies